About Khalil Barrage
Khalil Barrage is a director at Orthobond.
Form D filings also name Khalil Barrage as a director at Andros Medicines.
Khalil Barrage reports to the SEC as a director of 1 public company: Protagenic Therapeutics, Inc. ew (PTIX).
Khalil Barrage first appears on SEC filings in 2016.
Experience
This experience comes from Khalil Barrage's profile and from SEC filings. For roles taken from filings, the years are when the filings name Khalil Barrage in the role, so the role may have started earlier or lasted longer.
EL
ElevateBio Current
Board Member
2023 – Present
SE
Sensorion Current
Board Member
2019 – Present
Orthobond Corp Current
Director
2017 – Present · Monmouth Junction, NJ
Orthobond develops antibacterial surface treatments for medical device manufacturers.
IN
Invus Current
Managing Director
2003 – Present
OA
Onxeo S.A.
Board Member
2022 – 2025
PE
Protagenic Therapeutics, Inc. ew
Director
2007 – 2025 · Public company (PTIX)
CI
Celtaxsys, Inc.
Board Member
2013 – 2019
TG
The Olayan Group
Vice President
1988 – 2003
Key Colleagues at Startups
The people Khalil Barrage works with at each company, as listed on that company's latest Form D.
Orthobond Corp · Form D, Sep 1, 2026
EM
Eric Major
Chairman of the Board
LU
Lisa D'Urso
Director
AL
Anna Lutz
Director
KG
Kenneth Gall
Director
DN
David Nichols
CEO and director
PS
Peter Scaturro
Director
SM
Shailesh Maingi
Director
DH
David Helfet
Director
FC
Frank Cammisa
Chief Medical Officer and director
GC
Greg Cole
Director
PM
Pritam Mishra
Director
Andros Medicines Inc. · Form D, Jul 1, 2026
AB
Antoine Barouky
Director
JM
John Maraganore
President and CEO, director